BACKGROUND: Alcohol consumption is a well-established risk factor for breast cancer. This association is thought to be largely hormonally driven, so alcohol use may be more strongly associated with hormonally sensitive breast cancers. Few studies have evaluated how alcohol-related risk varies by breast cancer subtype. METHODS: We assessed the relationship between self-reported alcohol consumption and postmenopausal breast cancer risk among 87 724 women in the Women's Health Initiative Observational Study prospective cohort from 1993 through 1998. Multivariable adjusted Cox regression models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). All statistical tests were two-sided. RESULTS: A total of 2944 invasive breast cancer patients were diagnosed during follow-up through September 15, 2005. In multivariable adjusted analyses, alcohol consumption was positively related to risk of invasive breast cancer overall, invasive lobular carcinoma, and hormone receptor-positive tumors (all P(trend) ≤ .022). However, alcohol consumption was more strongly related to risk of certain types of invasive breast cancer compared with others. Compared with never drinkers, women who consumed seven or more alcoholic beverages per week had an almost twofold increased risk of hormone receptor-positive invasive lobular carcinoma (HR = 1.82; 95% CI = 1.18 to 2.81) but not a statistically significant increased risk of hormone receptor-positive invasive ductal carcinoma (HR = 1.14; 95% CI = 0.87 to 1.50; difference in HRs per drink per day among current drinkers = 1.15; 95% CI = 1.01 to 1.32, P = .042). The absolute rates of hormone receptor-positive lobular cancer among never drinkers and current drinkers were, 5.2 and 8.5 per 10 000 person-years, respectively, whereas for hormne receptor-positive ductal cancer they were 15.2 and 17.9 per 10 000 person-years, respectively. CONCLUSIONS: Alcohol use may be more strongly associated with risk of hormone-sensitive breast cancers than hormone-insensitive subtypes, suggesting distinct etiologic pathways for these two breast cancer subtypes.
BACKGROUND:Alcohol consumption is a well-established risk factor for breast cancer. This association is thought to be largely hormonally driven, so alcohol use may be more strongly associated with hormonally sensitive breast cancers. Few studies have evaluated how alcohol-related risk varies by breast cancer subtype. METHODS: We assessed the relationship between self-reported alcohol consumption and postmenopausal breast cancer risk among 87 724 women in the Women's Health Initiative Observational Study prospective cohort from 1993 through 1998. Multivariable adjusted Cox regression models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). All statistical tests were two-sided. RESULTS: A total of 2944 invasive breast cancerpatients were diagnosed during follow-up through September 15, 2005. In multivariable adjusted analyses, alcohol consumption was positively related to risk of invasive breast cancer overall, invasive lobular carcinoma, and hormone receptor-positive tumors (all P(trend) ≤ .022). However, alcohol consumption was more strongly related to risk of certain types of invasive breast cancer compared with others. Compared with never drinkers, women who consumed seven or more alcoholic beverages per week had an almost twofold increased risk of hormone receptor-positive invasive lobular carcinoma (HR = 1.82; 95% CI = 1.18 to 2.81) but not a statistically significant increased risk of hormone receptor-positive invasive ductal carcinoma (HR = 1.14; 95% CI = 0.87 to 1.50; difference in HRs per drink per day among current drinkers = 1.15; 95% CI = 1.01 to 1.32, P = .042). The absolute rates of hormone receptor-positive lobular cancer among never drinkers and current drinkers were, 5.2 and 8.5 per 10 000 person-years, respectively, whereas for hormne receptor-positive ductal cancer they were 15.2 and 17.9 per 10 000 person-years, respectively. CONCLUSIONS:Alcohol use may be more strongly associated with risk of hormone-sensitive breast cancers than hormone-insensitive subtypes, suggesting distinct etiologic pathways for these two breast cancer subtypes.
Authors: Janet R Daling; Kathleen E Malone; David R Doody; Lynda F Voigt; Leslie Bernstein; Ralph J Coates; Polly A Marchbanks; Sandra A Norman; Linda K Weiss; Giske Ursin; Jesse A Berlin; Ronald T Burkman; Dennis Deapen; Suzanne G Folger; Jill A McDonald; Michael S Simon; Brian L Strom; Phyllis A Wingo; Robert Spirtas Journal: Cancer Date: 2002-12-15 Impact factor: 6.860
Authors: J F Dorgan; D J Baer; P S Albert; J T Judd; E D Brown; D K Corle; W S Campbell; T J Hartman; A A Tejpar; B A Clevidence; C A Giffen; D W Chandler; F Z Stanczyk; P R Taylor Journal: J Natl Cancer Inst Date: 2001-05-02 Impact factor: 13.506
Authors: Laura M Newcomer; Polly A Newcomb; John D Potter; Yutaka Yasui; Amy Trentham-Dietz; Barry E Storer; Matthew P Longnecker; John A Baron; Janet R Daling Journal: Cancer Causes Control Date: 2003-04 Impact factor: 2.506
Authors: N Hamajima; K Hirose; K Tajima; T Rohan; E E Calle; C W Heath; R J Coates; J M Liff; R Talamini; N Chantarakul; S Koetsawang; D Rachawat; A Morabia; L Schuman; W Stewart; M Szklo; C Bain; F Schofield; V Siskind; P Band; A J Coldman; R P Gallagher; T G Hislop; P Yang; L M Kolonel; A M Y Nomura; J Hu; K C Johnson; Y Mao; S De Sanjosé; N Lee; P Marchbanks; H W Ory; H B Peterson; H G Wilson; P A Wingo; K Ebeling; D Kunde; P Nishan; J L Hopper; G Colditz; V Gajalanski; N Martin; T Pardthaisong; S Silpisornkosol; C Theetranont; B Boosiri; S Chutivongse; P Jimakorn; P Virutamasen; C Wongsrichanalai; M Ewertz; H O Adami; L Bergkvist; C Magnusson; I Persson; J Chang-Claude; C Paul; D C G Skegg; G F S Spears; P Boyle; T Evstifeeva; J R Daling; W B Hutchinson; K Malone; E A Noonan; J L Stanford; D B Thomas; N S Weiss; E White; N Andrieu; A Brêmond; F Clavel; B Gairard; J Lansac; L Piana; R Renaud; A Izquierdo; P Viladiu; H R Cuevas; P Ontiveros; A Palet; S B Salazar; N Aristizabel; A Cuadros; L Tryggvadottir; H Tulinius; A Bachelot; M G Lê; J Peto; S Franceschi; F Lubin; B Modan; E Ron; Y Wax; G D Friedman; R A Hiatt; F Levi; T Bishop; K Kosmelj; M Primic-Zakelj; B Ravnihar; J Stare; W L Beeson; G Fraser; R D Bullbrook; J Cuzick; S W Duffy; I S Fentiman; J L Hayward; D Y Wang; A J McMichael; K McPherson; R L Hanson; M C Leske; M C Mahoney; P C Nasca; A O Varma; A L Weinstein; T R Moller; H Olsson; J Ranstam; R A Goldbohm; P A van den Brandt; R A Apelo; J Baens; J R de la Cruz; B Javier; L B Lacaya; C A Ngelangel; C La Vecchia; E Negri; E Marubini; M Ferraroni; M Gerber; S Richardson; C Segala; D Gatei; P Kenya; A Kungu; J G Mati; L A Brinton; R Hoover; C Schairer; R Spirtas; H P Lee; M A Rookus; F E van Leeuwen; J A Schoenberg; M McCredie; M D Gammon; E A Clarke; L Jones; A Neil; M Vessey; D Yeates; P Appleby; E Banks; V Beral; D Bull; B Crossley; A Goodill; J Green; C Hermon; T Key; N Langston; C Lewis; G Reeves; R Collins; R Doll; R Peto; K Mabuchi; D Preston; P Hannaford; C Kay; L Rosero-Bixby; Y T Gao; F Jin; J-M Yuan; H Y Wei; T Yun; C Zhiheng; G Berry; J Cooper Booth; T Jelihovsky; R MacLennan; R Shearman; Q-S Wang; C-J Baines; A B Miller; C Wall; E Lund; H Stalsberg; X O Shu; W Zheng; K Katsouyanni; A Trichopoulou; D Trichopoulos; A Dabancens; L Martinez; R Molina; O Salas; F E Alexander; K Anderson; A R Folsom; B S Hulka; L Bernstein; S Enger; R W Haile; A Paganini-Hill; M C Pike; R K Ross; G Ursin; M C Yu; M P Longnecker; P Newcomb; L Bergkvist; A Kalache; T M M Farley; S Holck; O Meirik Journal: Br J Cancer Date: 2002-11-18 Impact factor: 7.640
Authors: Roni T Falk; Paige Maas; Catherine Schairer; Nilanjan Chatterjee; Jerome E Mabie; Christopher Cunningham; Saundra S Buys; Claudine Isaacs; Regina G Ziegler Journal: Am J Epidemiol Date: 2014-08-22 Impact factor: 4.897
Authors: Lindsay A Williams; Andrew F Olshan; Chi-Chen Hong; Elisa V Bandera; Lynn Rosenberg; Ting-Yuan David Cheng; Kathryn L Lunetta; Susan E McCann; Charles Poole; Laurence N Kolonel; Julie R Palmer; Christine B Ambrosone; Melissa A Troester Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-04-18 Impact factor: 4.254
Authors: Jun Wang; Xuehong Zhang; Andrew H Beck; Laura C Collins; Wendy Y Chen; Rulla M Tamimi; Aditi Hazra; Myles Brown; Bernard Rosner; Susan E Hankinson Journal: Horm Cancer Date: 2015-09-18 Impact factor: 3.869